-
1
-
-
79957534572
-
Targeting hypoxia in cancer therapy
-
Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011; 11: 393-410.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 393-410
-
-
Wilson, W.R.1
Hay, M.P.2
-
2
-
-
70450223507
-
Generating specificity and diversity in the transcriptional response to hypoxia
-
Lendahl U, Lee KL, Yang H, Poellinger L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet. 2009; 10: 821-832.
-
(2009)
Nat Rev Genet
, vol.10
, pp. 821-832
-
-
Lendahl, U.1
Lee, K.L.2
Yang, H.3
Poellinger, L.4
-
3
-
-
8144228566
-
Why do cancers have high aerobic glycolysis?
-
Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004; 4: 891-899.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 891-899
-
-
Gatenby, R.A.1
Gillies, R.J.2
-
4
-
-
80053563164
-
Interfering with pH regulation in tumours as a therapeutic strategy
-
Neri D, Supuran CT. Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov. 2011; 10: 767-777.
-
(2011)
Nat Rev Drug Discov
, vol.10
, pp. 767-777
-
-
Neri, D.1
Supuran, C.T.2
-
6
-
-
78649659788
-
pH control mechanisms of tumor survival and growth
-
Parks SK, Chiche J, Pouyssegur J. pH control mechanisms of tumor survival and growth. J Cell Physiol. 2011; 226: 299-308.
-
(2011)
J Cell Physiol
, vol.226
, pp. 299-308
-
-
Parks, S.K.1
Chiche, J.2
Pouyssegur, J.3
-
7
-
-
48349111944
-
Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression
-
Fang JS, Gillies RD, Gatenby RA. Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol. 2008; 18: 330-337.
-
(2008)
Semin Cancer Biol
, vol.18
, pp. 330-337
-
-
Fang, J.S.1
Gillies, R.D.2
Gatenby, R.A.3
-
8
-
-
37549013776
-
A microenvironmental model of carcinogenesis
-
Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer. 2008; 8: 56-61.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 56-61
-
-
Gatenby, R.A.1
Gillies, R.J.2
-
9
-
-
38849143765
-
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
-
Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov. 2008; 7: 168-181.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 168-181
-
-
Supuran, C.T.1
-
10
-
-
0027153461
-
Expression of MaTu-MN protein in human tumor cultures and in clinical specimens
-
Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer. 1993; 54: 268-274.
-
(1993)
Int J Cancer
, vol.54
, pp. 268-274
-
-
Zavada, J.1
Zavadova, Z.2
Pastorekova, S.3
Ciampor, F.4
Pastorek, J.5
Zelnik, V.6
-
11
-
-
0026561063
-
A novel quasi-viral agent, MaTu, is a two-component system
-
Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology. 1992; 187: 620-626.
-
(1992)
Virology
, vol.187
, pp. 620-626
-
-
Pastorekova, S.1
Zavadova, Z.2
Kostal, M.3
Babusikova, O.4
Zavada, J.5
-
12
-
-
0029975564
-
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships
-
Opavsky R, Pastorekova S, Zelnik V, Gibadulinova A, Stanbridge EJ, Zavada J, Kettmann R, Pastorek J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics. 1996; 33: 480-487.
-
(1996)
Genomics
, vol.33
, pp. 480-487
-
-
Opavsky, R.1
Pastorekova, S.2
Zelnik, V.3
Gibadulinova, A.4
Stanbridge, E.J.5
Zavada, J.6
Kettmann, R.7
Pastorek, J.8
-
13
-
-
0028111173
-
Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment
-
Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, Zat'ovicova M, Liao S, Portetelle D, Stanbridge EJ, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 1994; 9: 2877-2888.
-
(1994)
Oncogene
, vol.9
, pp. 2877-2888
-
-
Pastorek, J.1
Pastorekova, S.2
Callebaut, I.3
Mornon, J.P.4
Zelnik, V.5
Opavsky, R.6
Zat'ovicova, M.7
Liao, S.8
Portetelle, D.9
Stanbridge, E.J.10
-
14
-
-
70349490906
-
Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX
-
Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci U S A. 2009; 106: 16233-16238.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 16233-16238
-
-
Alterio, V.1
Hilvo, M.2
Di Fiore, A.3
Supuran, C.T.4
Pan, P.5
Parkkila, S.6
Scaloni, A.7
Pastorek, J.8
Pastorekova, S.9
Pedone, C.10
Scozzafava, A.11
Monti, S.M.12
De Simone, G.13
-
16
-
-
55549090009
-
Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes
-
Hilvo M, Baranauskiene L, Salzano AM, Scaloni A, Matulis D, Innocenti A, Scozzafava A, Monti SM, Di Fiore A, De Simone G, Lindfors M, Janis J, Valjakka J, Pastorekova S, Pastorek J, Kulomaa MS et al. Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem. 2008; 283: 27799-27809.
-
(2008)
J Biol Chem
, vol.283
, pp. 27799-27809
-
-
Hilvo, M.1
Baranauskiene, L.2
Salzano, A.M.3
Scaloni, A.4
Matulis, D.5
Innocenti, A.6
Scozzafava, A.7
Monti, S.M.8
Di Fiore, A.9
De Simone, G.10
Lindfors, M.11
Janis, J.12
Valjakka, J.13
Pastorekova, S.14
Pastorek, J.15
Kulomaa, M.S.16
-
17
-
-
74449091486
-
Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target
-
De Simone G, Supuran CT. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target. Biochim Biophys Acta. 2010; 1804: 404-409.
-
(2010)
Biochim Biophys Acta
, vol.1804
, pp. 404-409
-
-
De Simone, G.1
Supuran, C.T.2
-
18
-
-
70349199011
-
The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors
-
Innocenti A, Pastorekova S, Pastorek J, Scozzafava A, De Simone G, Supuran CT. The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors. Bioorg Med Chem Lett. 2009; 19: 5825-5828.
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 5825-5828
-
-
Innocenti, A.1
Pastorekova, S.2
Pastorek, J.3
Scozzafava, A.4
De Simone, G.5
Supuran, C.T.6
-
19
-
-
84255199558
-
Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors
-
DOI 10.1158/0008-5472.can-11-2520
-
Ditte P, Dequiedt F, Svastova E, Hulikova A, Ohradanova-Repic A, Zatovicova M, Csaderova L, Kopacek J, Supuran CT, Pastorekova S, Pastorek J. Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors. Cancer Res. 2011; 71: 7558-7567. DOI 10.1158/0008-5472.can-11-2520
-
(2011)
Cancer Res
, vol.71
, pp. 7558-7567
-
-
Ditte, P.1
Dequiedt, F.2
Svastova, E.3
Hulikova, A.4
Ohradanova-Repic, A.5
Zatovicova, M.6
Csaderova, L.7
Kopacek, J.8
Supuran, C.T.9
Pastorekova, S.10
Pastorek, J.11
-
20
-
-
62749124795
-
Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?
-
Kaluz S, Kaluzova M, Liao SY, Lerman M, Stanbridge EJ. Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? Biochim Biophys Acta. 2009; 1795: 162-172.
-
(2009)
Biochim Biophys Acta
, vol.1795
, pp. 162-172
-
-
Kaluz, S.1
Kaluzova, M.2
Liao, S.Y.3
Lerman, M.4
Stanbridge, E.J.5
-
21
-
-
0034671307
-
Hypoxia-inducible expression of tumor-associated carbonic anhydrases
-
Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000; 60: 7075-7083.
-
(2000)
Cancer Res
, vol.60
, pp. 7075-7083
-
-
Wykoff, C.C.1
Beasley, N.J.2
Watson, P.H.3
Turner, K.J.4
Pastorek, J.5
Sibtain, A.6
Wilson, G.D.7
Turley, H.8
Talks, K.L.9
Maxwell, P.H.10
Pugh, C.W.11
Ratcliffe, P.J.12
Harris, A.L.13
-
22
-
-
4344699403
-
Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion
-
Robertson N, Potter C, Harris AL. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res. 2004; 64: 6160-6165.
-
(2004)
Cancer Res
, vol.64
, pp. 6160-6165
-
-
Robertson, N.1
Potter, C.2
Harris, A.L.3
-
23
-
-
79955490807
-
Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors
-
Lou Y, McDonald PC, Oloumi A, Chia S, Ostlund C, Ahmadi A, Kyle A, Auf dem Keller U, Leung S, Huntsman D, Clarke B, Sutherland BW, Waterhouse D, Bally M, Roskelley C, Overall CM et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res. 2011; 71: 3364-3376.
-
(2011)
Cancer Res
, vol.71
, pp. 3364-3376
-
-
Lou, Y.1
McDonald, P.C.2
Oloumi, A.3
Chia, S.4
Ostlund, C.5
Ahmadi, A.6
Kyle, A.7
Auf dem Keller, U.8
Leung, S.9
Huntsman, D.10
Clarke, B.11
Sutherland, B.W.12
Waterhouse, D.13
Bally, M.14
Roskelley, C.15
Overall, C.M.16
-
24
-
-
0037374179
-
Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer
-
Kaluz S, Kaluzova M, Stanbridge EJ. Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer. Cancer Res. 2003; 63: 917-922.
-
(2003)
Cancer Res
, vol.63
, pp. 917-922
-
-
Kaluz, S.1
Kaluzova, M.2
Stanbridge, E.J.3
-
25
-
-
0036682009
-
Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase
-
Kaluz S, Kaluzova M, Chrastina A, Olive PL, Pastorekova S, Pastorek J, Lerman MI, Stanbridge EJ. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase. Cancer Res. 2002; 62: 4469-4477.
-
(2002)
Cancer Res
, vol.62
, pp. 4469-4477
-
-
Kaluz, S.1
Kaluzova, M.2
Chrastina, A.3
Olive, P.L.4
Pastorekova, S.5
Pastorek, J.6
Lerman, M.I.7
Stanbridge, E.J.8
-
26
-
-
0035893551
-
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer
-
Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res. 2001; 61: 8924-8929.
-
(2001)
Cancer Res
, vol.61
, pp. 8924-8929
-
-
Olive, P.L.1
Aquino-Parsons, C.2
MacPhail, S.H.3
Liao, S.Y.4
Raleigh, J.A.5
Lerman, M.I.6
Stanbridge, E.J.7
-
27
-
-
67649395578
-
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines
-
Shafee N, Kaluz S, Ru N, Stanbridge EJ. PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Lett. 2009; 282: 109-115.
-
(2009)
Cancer Lett
, vol.282
, pp. 109-115
-
-
Shafee, N.1
Kaluz, S.2
Ru, N.3
Stanbridge, E.J.4
-
28
-
-
33846562017
-
Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia
-
Ihnatko R, Kubes M, Takacova M, Sedlakova O, Sedlak J, Pastorek J, Kopacek J, Pastorekova S. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia. Int J Oncol. 2006; 29: 1025-1033.
-
(2006)
Int J Oncol
, vol.29
, pp. 1025-1033
-
-
Ihnatko, R.1
Kubes, M.2
Takacova, M.3
Sedlakova, O.4
Sedlak, J.5
Pastorek, J.6
Kopacek, J.7
Pastorekova, S.8
-
29
-
-
1842852597
-
Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells
-
Rafajova M, Zatovicova M, Kettmann R, Pastorek J, Pastorekova S. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol. 2004; 24: 995-1004.
-
(2004)
Int J Oncol
, vol.24
, pp. 995-1004
-
-
Rafajova, M.1
Zatovicova, M.2
Kettmann, R.3
Pastorek, J.4
Pastorekova, S.5
-
30
-
-
14844288340
-
Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells
-
Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys. 2005; 61: 1197-1207.
-
(2005)
Int J Radiat Oncol Biol Phys
, vol.61
, pp. 1197-1207
-
-
Vordermark, D.1
Kaffer, A.2
Riedl, S.3
Katzer, A.4
Flentje, M.5
-
31
-
-
77952878558
-
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy
-
Stillebroer AB, Mulders PF, Boerman OC, Oyen WJ, Oosterwijk E. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy. Eur Urol. 2010; 58: 75-83.
-
(2010)
Eur Urol
, vol.58
, pp. 75-83
-
-
Stillebroer, A.B.1
Mulders, P.F.2
Boerman, O.C.3
Oyen, W.J.4
Oosterwijk, E.5
-
32
-
-
2942733275
-
DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX
-
Kaluzova M, Kaluz S, Lerman MI, Stanbridge EJ. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Mol Cell Biol. 2004; 24: 5757-5766.
-
(2004)
Mol Cell Biol
, vol.24
, pp. 5757-5766
-
-
Kaluzova, M.1
Kaluz, S.2
Lerman, M.I.3
Stanbridge, E.J.4
-
33
-
-
0031040821
-
Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts
-
Pastorekova S, Parkkila S, Parkkila AK, Opavsky R, Zelnik V, Saarnio J, Pastorek J. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology. 1997; 112: 398-408.
-
(1997)
Gastroenterology
, vol.112
, pp. 398-408
-
-
Pastorekova, S.1
Parkkila, S.2
Parkkila, A.K.3
Opavsky, R.4
Zelnik, V.5
Saarnio, J.6
Pastorek, J.7
-
34
-
-
15644384121
-
Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity
-
Saarnio J, Parkkila S, Parkkila AK, Waheed A, Casey MC, Zhou XY, Pastorekova S, Pastorek J, Karttunen T, Haukipuro K, Kairaluoma MI, Sly WS. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem. 1998; 46: 497-504.
-
(1998)
J Histochem Cytochem
, vol.46
, pp. 497-504
-
-
Saarnio, J.1
Parkkila, S.2
Parkkila, A.K.3
Waheed, A.4
Casey, M.C.5
Zhou, X.Y.6
Pastorekova, S.7
Pastorek, J.8
Karttunen, T.9
Haukipuro, K.10
Kairaluoma, M.I.11
Sly, W.S.12
-
35
-
-
0034944417
-
Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts
-
Karhumaa P, Kaunisto K, Parkkila S, Waheed A, Pastorekova S, Pastorek J, Sly WS, Rajaniemi H. Expression of the transmembrane carbonic anhydrases, CA IX and CA XII, in the human male excurrent ducts. Mol Hum Reprod. 2001; 7: 611-616.
-
(2001)
Mol Hum Reprod
, vol.7
, pp. 611-616
-
-
Karhumaa, P.1
Kaunisto, K.2
Parkkila, S.3
Waheed, A.4
Pastorekova, S.5
Pastorek, J.6
Sly, W.S.7
Rajaniemi, H.8
-
36
-
-
0033775150
-
Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours
-
Kivela AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivela J, Parkkila AK, Pastorekova S, Pastorek J, Waheed A, Sly WS, Rajaniemi H. Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumours. Histochem Cell Biol. 2000; 114: 197-204.
-
(2000)
Histochem Cell Biol
, vol.114
, pp. 197-204
-
-
Kivela, A.J.1
Parkkila, S.2
Saarnio, J.3
Karttunen, T.J.4
Kivela, J.5
Parkkila, A.K.6
Pastorekova, S.7
Pastorek, J.8
Waheed, A.9
Sly, W.S.10
Rajaniemi, H.11
-
37
-
-
5444223388
-
Expression of carbonic anhydrase IX in mouse tissues
-
Hilvo M, Rafajova M, Pastorekova S, Pastorek J, Parkkila S. Expression of carbonic anhydrase IX in mouse tissues. J Histochem Cytochem. 2004; 52: 1313-1322.
-
(2004)
J Histochem Cytochem
, vol.52
, pp. 1313-1322
-
-
Hilvo, M.1
Rafajova, M.2
Pastorekova, S.3
Pastorek, J.4
Parkkila, S.5
-
38
-
-
33746918373
-
Expression of carbonic anhydrases IX and XII during mouse embryonic development
-
Kallio H, Pastorekova S, Pastorek J, Waheed A, Sly WS, Mannisto S, Heikinheimo M, Parkkila S. Expression of carbonic anhydrases IX and XII during mouse embryonic development. BMC Dev Biol. 2006; 6: 22.
-
(2006)
BMC Dev Biol
, vol.6
, pp. 22
-
-
Kallio, H.1
Pastorekova, S.2
Pastorek, J.3
Waheed, A.4
Sly, W.S.5
Mannisto, S.6
Heikinheimo, M.7
Parkkila, S.8
-
39
-
-
0035107383
-
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer
-
Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol. 2001; 158: 905-919.
-
(2001)
Am J Pathol
, vol.158
, pp. 905-919
-
-
Ivanov, S.1
Liao, S.Y.2
Ivanova, A.3
Danilkovitch-Miagkova, A.4
Tarasova, N.5
Weirich, G.6
Merrill, M.J.7
Proescholdt, M.A.8
Oldfield, E.H.9
Lee, J.10
Zavada, J.11
Waheed, A.12
Sly, W.13
Lerman, M.I.14
Stanbridge, E.J.15
-
40
-
-
0036893725
-
Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9
-
Gut MO, Parkkila S, Vernerova Z, Rohde E, Zavada J, Hocker M, Pastorek J, Karttunen T, Gibadulinova A, Zavadova Z, Knobeloch KP, Wiedenmann B, Svoboda J, Horak I, Pastorekova S. Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology. 2002; 123: 1889-1903.
-
(2002)
Gastroenterology
, vol.123
, pp. 1889-1903
-
-
Gut, M.O.1
Parkkila, S.2
Vernerova, Z.3
Rohde, E.4
Zavada, J.5
Hocker, M.6
Pastorek, J.7
Karttunen, T.8
Gibadulinova, A.9
Zavadova, Z.10
Knobeloch, K.P.11
Wiedenmann, B.12
Svoboda, J.13
Horak, I.14
Pastorekova, S.15
-
41
-
-
27144527814
-
Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C
-
Leppilampi M, Karttunen TJ, Kivela J, Gut MO, Pastorekova S, Pastorek J, Parkkila S. Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: studies on two strains C57/BL6 and BALB/C. Transgenic Res. 2005; 14: 655-663.
-
(2005)
Transgenic Res
, vol.14
, pp. 655-663
-
-
Leppilampi, M.1
Karttunen, T.J.2
Kivela, J.3
Gut, M.O.4
Pastorekova, S.5
Pastorek, J.6
Parkkila, S.7
-
42
-
-
84856232752
-
Brain phenotype of carbonic anhydrase IX-deficient mice
-
Pan PW, Parkkila AK, Autio S, Hilvo M, Sormunen R, Pastorekova S, Pastorek J, Haapasalo H, Parkkila S. Brain phenotype of carbonic anhydrase IX-deficient mice. Transgenic Res. 2012; 21: 163-176.
-
(2012)
Transgenic Res
, vol.21
, pp. 163-176
-
-
Pan, P.W.1
Parkkila, A.K.2
Autio, S.3
Hilvo, M.4
Sormunen, R.5
Pastorekova, S.6
Pastorek, J.7
Haapasalo, H.8
Parkkila, S.9
-
43
-
-
33645921628
-
Carbonic anhydrase gene expression in CA II-deficient (Car2-/-) and CA IX-deficient (Car9-/-) mice
-
Pan P, Leppilampi M, Pastorekova S, Pastorek J, Waheed A, Sly WS, Parkkila S. Carbonic anhydrase gene expression in CA II-deficient (Car2-/-) and CA IX-deficient (Car9-/-) mice. J Physiol. 2006; 571: 319-327.
-
(2006)
J Physiol
, vol.571
, pp. 319-327
-
-
Pan, P.1
Leppilampi, M.2
Pastorekova, S.3
Pastorek, J.4
Waheed, A.5
Sly, W.S.6
Parkkila, S.7
-
44
-
-
0037315252
-
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer
-
Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol. 2003; 21: 473-482.
-
(2003)
J Clin Oncol
, vol.21
, pp. 473-482
-
-
Swinson, D.E.1
Jones, J.L.2
Richardson, D.3
Wykoff, C.4
Turley, H.5
Pastorek, J.6
Taub, N.7
Harris, A.L.8
O'Byrne, K.J.9
-
45
-
-
23744479831
-
Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
-
Kim SJ, Rabbani ZN, Dewhirst MW, Vujaskovic Z, Vollmer RT, Schreiber EG, Oosterwijk E, Kelley MJ. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer. 2005; 49: 325-335.
-
(2005)
Lung Cancer
, vol.49
, pp. 325-335
-
-
Kim, S.J.1
Rabbani, Z.N.2
Dewhirst, M.W.3
Vujaskovic, Z.4
Vollmer, R.T.5
Schreiber, E.G.6
Oosterwijk, E.7
Kelley, M.J.8
-
46
-
-
77952888155
-
High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
-
Ilie M, Mazure NM, Hofman V, Ammadi RE, Ortholan C, Bonnetaud C, Havet K, Venissac N, Mograbi B, Mouroux J, Pouyssegur J, Hofman P. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer. 2010; 102: 1627-1635.
-
(2010)
Br J Cancer
, vol.102
, pp. 1627-1635
-
-
Ilie, M.1
Mazure, N.M.2
Hofman, V.3
Ammadi, R.E.4
Ortholan, C.5
Bonnetaud, C.6
Havet, K.7
Venissac, N.8
Mograbi, B.9
Mouroux, J.10
Pouyssegur, J.11
Hofman, P.12
-
47
-
-
0031819881
-
Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation
-
Saarnio J, Parkkila S, Parkkila AK, Haukipuro K, Pastorekova S, Pastorek J, Kairaluoma MI, Karttunen TJ. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol. 1998; 153: 279-285.
-
(1998)
Am J Pathol
, vol.153
, pp. 279-285
-
-
Saarnio, J.1
Parkkila, S.2
Parkkila, A.K.3
Haukipuro, K.4
Pastorekova, S.5
Pastorek, J.6
Kairaluoma, M.I.7
Karttunen, T.J.8
-
48
-
-
62549099960
-
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer
-
Korkeila E, Talvinen K, Jaakkola PM, Minn H, Syrjanen K, Sundstrom J, Pyrhonen S. Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer. 2009; 100: 874-880.
-
(2009)
Br J Cancer
, vol.100
, pp. 874-880
-
-
Korkeila, E.1
Talvinen, K.2
Jaakkola, P.M.3
Minn, H.4
Syrjanen, K.5
Sundstrom, J.6
Pyrhonen, S.7
-
49
-
-
0035881075
-
Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma
-
Chia SK, Wykoff CC, Watson PH, Han C, Leek RD, Pastorek J, Gatter KC, Ratcliffe P, Harris AL. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol. 2001; 19: 3660-3668.
-
(2001)
J Clin Oncol
, vol.19
, pp. 3660-3668
-
-
Chia, S.K.1
Wykoff, C.C.2
Watson, P.H.3
Han, C.4
Leek, R.D.5
Pastorek, J.6
Gatter, K.C.7
Ratcliffe, P.8
Harris, A.L.9
-
50
-
-
33847649279
-
HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome
-
Trastour C, Benizri E, Ettore F, Ramaioli A, Chamorey E, Pouyssegur J, Berra E. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer. 2007; 120: 1451-1458.
-
(2007)
Int J Cancer
, vol.120
, pp. 1451-1458
-
-
Trastour, C.1
Benizri, E.2
Ettore, F.3
Ramaioli, A.4
Chamorey, E.5
Pouyssegur, J.6
Berra, E.7
-
51
-
-
58749090733
-
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
-
Tan EY, Yan M, Campo L, Han C, Takano E, Turley H, Candiloro I, Pezzella F, Gatter KC, Millar EK, O'Toole SA, McNeil CM, Crea P, Segara D, Sutherland RL, Harris AL et al. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer. 2009; 100: 405-411.
-
(2009)
Br J Cancer
, vol.100
, pp. 405-411
-
-
Tan, E.Y.1
Yan, M.2
Campo, L.3
Han, C.4
Takano, E.5
Turley, H.6
Candiloro, I.7
Pezzella, F.8
Gatter, K.C.9
Millar, E.K.10
O'Toole, S.A.11
McNeil, C.M.12
Crea, P.13
Segara, D.14
Sutherland, R.L.15
Harris, A.L.16
-
52
-
-
0035418586
-
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix
-
Loncaster JA, Harris AL, Davidson SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CM. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 2001; 61: 6394-6399.
-
(2001)
Cancer Res
, vol.61
, pp. 6394-6399
-
-
Loncaster, J.A.1
Harris, A.L.2
Davidson, S.E.3
Logue, J.P.4
Hunter, R.D.5
Wycoff, C.C.6
Pastorek, J.7
Ratcliffe, P.J.8
Stratford, I.J.9
West, C.M.10
-
53
-
-
33644517250
-
Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer
-
Kim JY, Shin HJ, Kim TH, Cho KH, Shin KH, Kim BK, Roh JW, Lee S, Park SY, Hwang YJ, Han IO. Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer. J Cancer Res Clin Oncol. 2006; 132: 302-308.
-
(2006)
J Cancer Res Clin Oncol
, vol.132
, pp. 302-308
-
-
Kim, J.Y.1
Shin, H.J.2
Kim, T.H.3
Cho, K.H.4
Shin, K.H.5
Kim, B.K.6
Roh, J.W.7
Lee, S.8
Park, S.Y.9
Hwang, Y.J.10
Han, I.O.11
-
54
-
-
33846661210
-
Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer
-
Lee S, Shin HJ, Han IO, Hong EK, Park SY, Roh JW, Shin KH, Kim TH, Kim JY. Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer. Cancer Sci. 2007; 98: 329-333.
-
(2007)
Cancer Sci
, vol.98
, pp. 329-333
-
-
Lee, S.1
Shin, H.J.2
Han, I.O.3
Hong, E.K.4
Park, S.Y.5
Roh, J.W.6
Shin, K.H.7
Kim, T.H.8
Kim, J.Y.9
-
55
-
-
78651106761
-
Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
-
Woelber L, Kress K, Kersten JF, Choschzick M, Kilic E, Herwig U, Lindner C, Schwarz J, Jaenicke F, Mahner S, Milde-Langosch K, Mueller V, Ihnen M. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. BMC Cancer. 2011; 11: 12.
-
(2011)
BMC Cancer
, vol.11
, pp. 12
-
-
Woelber, L.1
Kress, K.2
Kersten, J.F.3
Choschzick, M.4
Kilic, E.5
Herwig, U.6
Lindner, C.7
Schwarz, J.8
Jaenicke, F.9
Mahner, S.10
Milde-Langosch, K.11
Mueller, V.12
Ihnen, M.13
-
56
-
-
0242298213
-
GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON
-
Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer. 2003; 89: 1290-1297.
-
(2003)
Br J Cancer
, vol.89
, pp. 1290-1297
-
-
Hoskin, P.J.1
Sibtain, A.2
Daley, F.M.3
Wilson, G.D.4
-
57
-
-
80052419706
-
Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer
-
Choschzick M, Oosterwijk E, Muller V, Woelber L, Simon R, Moch H, Tennstedt P. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Arch. 2011; 459: 193-200.
-
(2011)
Virchows Arch
, vol.459
, pp. 193-200
-
-
Choschzick, M.1
Oosterwijk, E.2
Muller, V.3
Woelber, L.4
Simon, R.5
Moch, H.6
Tennstedt, P.7
-
58
-
-
77950886638
-
The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis
-
Nordfors K, Haapasalo J, Korja M, Niemela A, Laine J, Parkkila AK, Pastorekova S, Pastorek J, Waheed A, Sly WS, Parkkila S, Haapasalo H. The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. BMC Cancer. 2010; 10: 148.
-
(2010)
BMC Cancer
, vol.10
, pp. 148
-
-
Nordfors, K.1
Haapasalo, J.2
Korja, M.3
Niemela, A.4
Laine, J.5
Parkkila, A.K.6
Pastorekova, S.7
Pastorek, J.8
Waheed, A.9
Sly, W.S.10
Parkkila, S.11
Haapasalo, H.12
-
59
-
-
11344251027
-
Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma
-
Hoogsteen IJ, Marres HA, Wijffels KI, Rijken PF, Peters JP, van den Hoogen FJ, Oosterwijk E, van der Kogel AJ, Kaanders JH. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res. 2005; 11: 97-106.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 97-106
-
-
Hoogsteen, I.J.1
Marres, H.A.2
Wijffels, K.I.3
Rijken, P.F.4
Peters, J.P.5
van den Hoogen, F.J.6
Oosterwijk, E.7
van der Kogel, A.J.8
Kaanders, J.H.9
-
60
-
-
26844468059
-
The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy
-
De Schutter H, Landuyt W, Verbeken E, Goethals L, Hermans R, Nuyts S. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy. BMC Cancer. 2005; 5: 42.
-
(2005)
BMC Cancer
, vol.5
, pp. 42
-
-
De Schutter, H.1
Landuyt, W.2
Verbeken, E.3
Goethals, L.4
Hermans, R.5
Nuyts, S.6
-
61
-
-
33644849887
-
Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial
-
Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol. 2006; 24: 727-735.
-
(2006)
J Clin Oncol
, vol.24
, pp. 727-735
-
-
Koukourakis, M.I.1
Bentzen, S.M.2
Giatromanolaki, A.3
Wilson, G.D.4
Daley, F.M.5
Saunders, M.I.6
Dische, S.7
Sivridis, E.8
Harris, A.L.9
-
62
-
-
77950511856
-
Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients
-
Eckert AW, Lautner MH, Schutze A, Bolte K, Bache M, Kappler M, Schubert J, Taubert H, Bilkenroth U. Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients. J Oral Pathol Med. 2010; 39: 313-317.
-
(2010)
J Oral Pathol Med
, vol.39
, pp. 313-317
-
-
Eckert, A.W.1
Lautner, M.H.2
Schutze, A.3
Bolte, K.4
Bache, M.5
Kappler, M.6
Schubert, J.7
Taubert, H.8
Bilkenroth, U.9
-
63
-
-
48949096355
-
Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma
-
Choi SW, Kim JY, Park JY, Cha IH, Kim J, Lee S. Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognosis in surgically treated oral squamous cell carcinoma. Hum Pathol. 2008; 39: 1317-1322.
-
(2008)
Hum Pathol
, vol.39
, pp. 1317-1322
-
-
Choi, S.W.1
Kim, J.Y.2
Park, J.Y.3
Cha, I.H.4
Kim, J.5
Lee, S.6
-
64
-
-
33846211525
-
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer
-
Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer. 2007; 96: 104-109.
-
(2007)
Br J Cancer
, vol.96
, pp. 104-109
-
-
Hussain, S.A.1
Ganesan, R.2
Reynolds, G.3
Gross, L.4
Stevens, A.5
Pastorek, J.6
Murray, P.G.7
Perunovic, B.8
Anwar, M.S.9
Billingham, L.10
James, N.D.11
Spooner, D.12
Poole, C.J.13
Rea, D.W.14
Palmer, D.H.15
-
65
-
-
63449135054
-
Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker
-
Klatte T, Seligson DB, Rao JY, Yu H, de Martino M, Kawaoka K, Wong SG, Belldegrun AS, Pantuck AJ. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Cancer. 2009; 115: 1448-1458.
-
(2009)
Cancer
, vol.115
, pp. 1448-1458
-
-
Klatte, T.1
Seligson, D.B.2
Rao, J.Y.3
Yu, H.4
de Martino, M.5
Kawaoka, K.6
Wong, S.G.7
Belldegrun, A.S.8
Pantuck, A.J.9
-
66
-
-
31544475474
-
Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis
-
Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastorekova S, Pastorek J, Parkkila SM, Haapasalo HK. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res. 2006; 12: 473-477.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 473-477
-
-
Haapasalo, J.A.1
Nordfors, K.M.2
Hilvo, M.3
Rantala, I.J.4
Soini, Y.5
Parkkila, A.K.6
Pastorekova, S.7
Pastorek, J.8
Parkkila, S.M.9
Haapasalo, H.K.10
-
67
-
-
58549107792
-
Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study
-
Debucquoy A, Goethals L, Libbrecht L, Perneel C, Geboes K, Ectors N, McBride WH, Haustermans K. Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study. Int J Colorectal Dis. 2009; 24: 129-138.
-
(2009)
Int J Colorectal Dis
, vol.24
, pp. 129-138
-
-
Debucquoy, A.1
Goethals, L.2
Libbrecht, L.3
Perneel, C.4
Geboes, K.5
Ectors, N.6
McBride, W.H.7
Haustermans, K.8
-
68
-
-
39549085348
-
Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer
-
Kirkpatrick JP, Rabbani ZN, Bentley RC, Hardee ME, Karol S, Meyer J, Oosterwijk E, Havrilesky L, Secord AA, Vujaskovic Z, Dewhirst MW, Jones EL. Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer. Biomark Insights. 2008; 3: 45-55.
-
(2008)
Biomark Insights
, vol.3
, pp. 45-55
-
-
Kirkpatrick, J.P.1
Rabbani, Z.N.2
Bentley, R.C.3
Hardee, M.E.4
Karol, S.5
Meyer, J.6
Oosterwijk, E.7
Havrilesky, L.8
Secord, A.A.9
Vujaskovic, Z.10
Dewhirst, M.W.11
Jones, E.L.12
-
69
-
-
75749122186
-
Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study
-
Liao SY, Darcy KM, Randall LM, Tian C, Monk BJ, Burger RA, Fruehauf JP, Peters WA, Stock RJ, Stanbridge EJ. Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010; 116: 452-458.
-
(2010)
Gynecol Oncol
, vol.116
, pp. 452-458
-
-
Liao, S.Y.1
Darcy, K.M.2
Randall, L.M.3
Tian, C.4
Monk, B.J.5
Burger, R.A.6
Fruehauf, J.P.7
Peters, W.A.8
Stock, R.J.9
Stanbridge, E.J.10
-
70
-
-
0345491970
-
Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas
-
Hedley D, Pintilie M, Woo J, Morrison A, Birle D, Fyles A, Milosevic M, Hill R. Carbonic anhydrase IX expression, hypoxia, and prognosis in patients with uterine cervical carcinomas. Clin Cancer Res. 2003; 9: 5666-5674.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5666-5674
-
-
Hedley, D.1
Pintilie, M.2
Woo, J.3
Morrison, A.4
Birle, D.5
Fyles, A.6
Milosevic, M.7
Hill, R.8
-
71
-
-
34248191183
-
Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype
-
Garcia S, Dales JP, Charafe-Jauffret E, Carpentier-Meunier S, Andrac-Meyer L, Jacquemier J, Andonian C, Lavaut MN, Allasia C, Bonnier P, Charpin C. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype. Hum Pathol. 2007; 38: 830-841.
-
(2007)
Hum Pathol
, vol.38
, pp. 830-841
-
-
Garcia, S.1
Dales, J.P.2
Charafe-Jauffret, E.3
Carpentier-Meunier, S.4
Andrac-Meyer, L.5
Jacquemier, J.6
Andonian, C.7
Lavaut, M.N.8
Allasia, C.9
Bonnier, P.10
Charpin, C.11
-
72
-
-
77950189592
-
Serum carbonic anhydrase IX during first-line therapy of ovarian cancer
-
Woelber L, Mueller V, Eulenburg C, Schwarz J, Carney W, Jaenicke F, Milde-Langosch K, Mahner S. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer. Gynecol Oncol. 2010; 117: 183-188.
-
(2010)
Gynecol Oncol
, vol.117
, pp. 183-188
-
-
Woelber, L.1
Mueller, V.2
Eulenburg, C.3
Schwarz, J.4
Carney, W.5
Jaenicke, F.6
Milde-Langosch, K.7
Mahner, S.8
-
73
-
-
68149108604
-
Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract
-
Hyrsl L, Zavada J, Zavadova Z, Kawaciuk I, Vesely S, Skapa P. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract. Neoplasma. 2009; 56: 298-302.
-
(2009)
Neoplasma
, vol.56
, pp. 298-302
-
-
Hyrsl, L.1
Zavada, J.2
Zavadova, Z.3
Kawaciuk, I.4
Vesely, S.5
Skapa, P.6
-
74
-
-
79951476812
-
Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer
-
Kock L, Mahner S, Choschzick M, Eulenburg C, Milde-Langosch K, Schwarz J, Jaenicke F, Muller V, Woelber L. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer. Int J Gynecol Cancer. 2011; 21: 141-148.
-
(2011)
Int J Gynecol Cancer
, vol.21
, pp. 141-148
-
-
Kock, L.1
Mahner, S.2
Choschzick, M.3
Eulenburg, C.4
Milde-Langosch, K.5
Schwarz, J.6
Jaenicke, F.7
Muller, V.8
Woelber, L.9
-
75
-
-
79960074590
-
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
-
Muller V, Riethdorf S, Rack B, Janni W, Fasching PA, Solomayer E, Aktas B, Kasimir-Bauer S, Zeitz J, Pantel K, Fehm T. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer. Breast Cancer Res. 2011; 13: R71.
-
(2011)
Breast Cancer Res
, vol.13
-
-
Muller, V.1
Riethdorf, S.2
Rack, B.3
Janni, W.4
Fasching, P.A.5
Solomayer, E.6
Aktas, B.7
Kasimir-Bauer, S.8
Zeitz, J.9
Pantel, K.10
Fehm, T.11
-
76
-
-
78650308850
-
New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation
-
Swietach P, Hulikova A, Vaughan-Jones RD, Harris AL. New insights into the physiological role of carbonic anhydrase IX in tumour pH regulation. Oncogene. 2010; 29: 6509-6521.
-
(2010)
Oncogene
, vol.29
, pp. 6509-6521
-
-
Swietach, P.1
Hulikova, A.2
Vaughan-Jones, R.D.3
Harris, A.L.4
-
77
-
-
67749145635
-
The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths
-
Swietach P, Patiar S, Supuran CT, Harris AL, Vaughan-Jones RD. The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths. J Biol Chem. 2009; 284: 20299-20310.
-
(2009)
J Biol Chem
, vol.284
, pp. 20299-20310
-
-
Swietach, P.1
Patiar, S.2
Supuran, C.T.3
Harris, A.L.4
Vaughan-Jones, R.D.5
-
78
-
-
71749105278
-
Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX
-
Hulikova A, Zatovicova M, Svastova E, Ditte P, Brasseur R, Kettmann R, Supuran CT, Kopacek J, Pastorek J, Pastorekova S. Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX. FEBS Lett. 2009; 583: 3563-3568.
-
(2009)
FEBS Lett
, vol.583
, pp. 3563-3568
-
-
Hulikova, A.1
Zatovicova, M.2
Svastova, E.3
Ditte, P.4
Brasseur, R.5
Kettmann, R.6
Supuran, C.T.7
Kopacek, J.8
Pastorek, J.9
Pastorekova, S.10
-
79
-
-
78649813619
-
Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain
-
Zatovicova M, Jelenska L, Hulikova A, Csaderova L, Ditte Z, Ditte P, Goliasova T, Pastorek J, Pastorekova S. Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des. 2010; 16: 3255-3263.
-
(2010)
Curr Pharm Des
, vol.16
, pp. 3255-3263
-
-
Zatovicova, M.1
Jelenska, L.2
Hulikova, A.3
Csaderova, L.4
Ditte, Z.5
Ditte, P.6
Goliasova, T.7
Pastorek, J.8
Pastorekova, S.9
-
80
-
-
28244451574
-
The role of carbonic anhydrase IX overexpression in kidney cancer
-
Dorai T, Sawczuk IS, Pastorek J, Wiernik PH, Dutcher JP. The role of carbonic anhydrase IX overexpression in kidney cancer. Eur J Cancer. 2005; 41: 2935-2947.
-
(2005)
Eur J Cancer
, vol.41
, pp. 2935-2947
-
-
Dorai, T.1
Sawczuk, I.S.2
Pastorek, J.3
Wiernik, P.H.4
Dutcher, J.P.5
-
81
-
-
0142121458
-
Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin
-
Svastova E, Zilka N, Zat'ovicova M, Gibadulinova A, Ciampor F, Pastorek J, Pastorekova S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin. Exp Cell Res. 2003; 290: 332-345.
-
(2003)
Exp Cell Res
, vol.290
, pp. 332-345
-
-
Svastova, E.1
Zilka, N.2
Zat'ovicova, M.3
Gibadulinova, A.4
Ciampor, F.5
Pastorek, J.6
Pastorekova, S.7
-
82
-
-
79953138420
-
Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
-
Shin HJ, Rho SB, Jung DC, Han IO, Oh ES, Kim JY. Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion. J Cell Sci. 2011; 124: 1077-1087.
-
(2011)
J Cell Sci
, vol.124
, pp. 1077-1087
-
-
Shin, H.J.1
Rho, S.B.2
Jung, D.C.3
Han, I.O.4
Oh, E.S.5
Kim, J.Y.6
-
83
-
-
77956253534
-
Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells
-
Cianchi F, Vinci MC, Supuran CT, Peruzzi B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini A, Masini E, Puccetti L. Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells. J Pharmacol Exp Ther. 2010; 334: 710-719.
-
(2010)
J Pharmacol Exp Ther
, vol.334
, pp. 710-719
-
-
Cianchi, F.1
Vinci, M.C.2
Supuran, C.T.3
Peruzzi, B.4
De Giuli, P.5
Fasolis, G.6
Perigli, G.7
Pastorekova, S.8
Papucci, L.9
Pini, A.10
Masini, E.11
Puccetti, L.12
-
84
-
-
79960359073
-
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
-
Dubois L, Peeters S, Lieuwes NG, Geusens N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogne JM, Supuran CT, Harris AL, Masereel B, Lambin P. Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol. 2011; 99: 424-431.
-
(2011)
Radiother Oncol
, vol.99
, pp. 424-431
-
-
Dubois, L.1
Peeters, S.2
Lieuwes, N.G.3
Geusens, N.4
Thiry, A.5
Wigfield, S.6
Carta, F.7
McIntyre, A.8
Scozzafava, A.9
Dogne, J.M.10
Supuran, C.T.11
Harris, A.L.12
Masereel, B.13
Lambin, P.14
-
85
-
-
80053923216
-
Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors
-
Morris JC, Chiche J, Grellier C, Lopez M, Bornaghi LF, Maresca A, Supuran CT, Pouyssegur J, Poulsen SA. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors. J Med Chem. 2011; 54: 6905-6918.
-
(2011)
J Med Chem
, vol.54
, pp. 6905-6918
-
-
Morris, J.C.1
Chiche, J.2
Grellier, C.3
Lopez, M.4
Bornaghi, L.F.5
Maresca, A.6
Supuran, C.T.7
Pouyssegur, J.8
Poulsen, S.A.9
-
86
-
-
58249094845
-
Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH
-
Chiche J, Ilc K, Laferriere J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouyssegur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 2009; 69: 358-368.
-
(2009)
Cancer Res
, vol.69
, pp. 358-368
-
-
Chiche, J.1
Ilc, K.2
Laferriere, J.3
Trottier, E.4
Dayan, F.5
Mazure, N.M.6
Brahimi-Horn, M.C.7
Pouyssegur, J.8
-
87
-
-
0022502868
-
Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney
-
Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EK, Jonas U, Zwartendijk J, Warnaar SO. Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer. 1986; 38: 489-494.
-
(1986)
Int J Cancer
, vol.38
, pp. 489-494
-
-
Oosterwijk, E.1
Ruiter, D.J.2
Hoedemaeker, P.J.3
Pauwels, E.K.4
Jonas, U.5
Zwartendijk, J.6
Warnaar, S.O.7
-
88
-
-
0038118505
-
Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma
-
Chrastina A, Zavada J, Parkkila S, Kaluz S, Kaluzova M, Rajcani J, Pastorek J, Pastorekova S. Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. Int J Cancer. 2003; 105: 873-881.
-
(2003)
Int J Cancer
, vol.105
, pp. 873-881
-
-
Chrastina, A.1
Zavada, J.2
Parkkila, S.3
Kaluz, S.4
Kaluzova, M.5
Rajcani, J.6
Pastorek, J.7
Pastorekova, S.8
-
89
-
-
0037270299
-
Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody
-
Chrastina A, Pastorekova S, Pastorek J. Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody. Neoplasma. 2003; 50: 13-21.
-
(2003)
Neoplasma
, vol.50
, pp. 13-21
-
-
Chrastina, A.1
Pastorekova, S.2
Pastorek, J.3
-
90
-
-
38849201787
-
Carbonic anhydrase IX/G250/MN: a molecule too good to be true?
-
Oosterwijk E. Carbonic anhydrase IX/G250/MN: a molecule too good to be true? BJU Int. 2008; 101: 527-528.
-
(2008)
BJU Int
, vol.101
, pp. 527-528
-
-
Oosterwijk, E.1
-
91
-
-
0030017852
-
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors
-
Surfus JE, Hank JA, Oosterwijk E, Welt S, Lindstrom MJ, Albertini MR, Schiller JH, Sondel PM. Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors. J Immunother Emphasis Tumor Immunol. 1996; 19: 184-191.
-
(1996)
J Immunother Emphasis Tumor Immunol
, vol.19
, pp. 184-191
-
-
Surfus, J.E.1
Hank, J.A.2
Oosterwijk, E.3
Welt, S.4
Lindstrom, M.J.5
Albertini, M.R.6
Schiller, J.H.7
Sondel, P.M.8
-
92
-
-
78751650361
-
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX(R)) and interferon-alpha-2a in metastatic renal cell carcinoma patients
-
Siebels M, Rohrmann K, Oberneder R, Stahler M, Haseke N, Beck J, Hofmann R, Kindler M, Kloepfer P, Stief C. A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX(R)) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World J Urol. 2011; 29: 121-126.
-
(2011)
World J Urol
, vol.29
, pp. 121-126
-
-
Siebels, M.1
Rohrmann, K.2
Oberneder, R.3
Stahler, M.4
Haseke, N.5
Beck, J.6
Hofmann, R.7
Kindler, M.8
Kloepfer, P.9
Stief, C.10
-
93
-
-
34548083337
-
A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma
-
Davis ID, Wiseman GA, Lee FT, Gansen DN, Hopkins W, Papenfuss AT, Liu Z, Moynihan TJ, Croghan GA, Adjei AA, Hoffman EW, Ingle JN, Old LJ, Scott AM. A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma. Cancer Immun. 2007; 7: 13.
-
(2007)
Cancer Immun
, vol.7
, pp. 13
-
-
Davis, I.D.1
Wiseman, G.A.2
Lee, F.T.3
Gansen, D.N.4
Hopkins, W.5
Papenfuss, A.T.6
Liu, Z.7
Moynihan, T.J.8
Croghan, G.A.9
Adjei, A.A.10
Hoffman, E.W.11
Ingle, J.N.12
Old, L.J.13
Scott, A.M.14
-
94
-
-
79952488307
-
Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX
-
Murri-Plesko MT, Hulikova A, Oosterwijk E, Scott AM, Zortea A, Harris AL, Ritter G, Old L, Bauer S, Swietach P, Renner C. Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX. Eur J Pharmacol. 2011; 657: 173-183.
-
(2011)
Eur J Pharmacol
, vol.657
, pp. 173-183
-
-
Murri-Plesko, M.T.1
Hulikova, A.2
Oosterwijk, E.3
Scott, A.M.4
Zortea, A.5
Harris, A.L.6
Ritter, G.7
Old, L.8
Bauer, S.9
Swietach, P.10
Renner, C.11
-
95
-
-
68749119336
-
Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours
-
Ahlskog JK, Schliemann C, Marlind J, Qureshi U, Ammar A, Pedley RB, Neri D. Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. Br J Cancer. 2009; 101: 645-657.
-
(2009)
Br J Cancer
, vol.101
, pp. 645-657
-
-
Ahlskog, J.K.1
Schliemann, C.2
Marlind, J.3
Qureshi, U.4
Ammar, A.5
Pedley, R.B.6
Neri, D.7
-
96
-
-
77949716901
-
Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology
-
Xu C, Lo A, Yammanuru A, Tallarico AS, Brady K, Murakami A, Barteneva N, Zhu Q, Marasco WA. Unique biological properties of catalytic domain directed human anti-CAIX antibodies discovered through phage-display technology. PLoS One. 2010; 5: e9625.
-
(2010)
PLoS One
, vol.5
-
-
Xu, C.1
Lo, A.2
Yammanuru, A.3
Tallarico, A.S.4
Brady, K.5
Murakami, A.6
Barteneva, N.7
Zhu, Q.8
Marasco, W.A.9
-
97
-
-
1542399581
-
Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re
-
Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re. J Nucl Med. 2004; 45: 327-337.
-
(2004)
J Nucl Med
, vol.45
, pp. 327-337
-
-
Brouwers, A.H.1
van Eerd, J.E.2
Frielink, C.3
Oosterwijk, E.4
Oyen, W.J.5
Corstens, F.H.6
Boerman, O.C.7
-
98
-
-
84855402294
-
Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging
-
Stillebroer AB, Zegers CM, Boerman OC, Oosterwijk E, Mulders PF, O'Donoghue JA, Visser EP, Oyen WJ. Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging. J Nucl Med. 2012; 53: 82-89.
-
(2012)
J Nucl Med
, vol.53
, pp. 82-89
-
-
Stillebroer, A.B.1
Zegers, C.M.2
Boerman, O.C.3
Oosterwijk, E.4
Mulders, P.F.5
O'Donoghue, J.A.6
Visser, E.P.7
Oyen, W.J.8
-
99
-
-
84863116661
-
Therapeutic Mechanism and Efficacy of the Antibody Drug-Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9
-
DOI 10.1158/1535-7163.mct-11-0523
-
Petrul HM, Schatz CA, Kopitz CC, Adnane L, McCabe TJ, Trail PA, Ha S, Chang YS, Voznesensky A, Ranges G, Tamburini P. Therapeutic Mechanism and Efficacy of the Antibody Drug-Conjugate BAY 79-4620 Targeting Human Carbonic Anhydrase 9. Mol Cancer Ther. 2011. DOI 10.1158/1535-7163.mct-11-0523
-
(2011)
Mol Cancer Ther
, pp. 11-0523
-
-
Petrul, H.M.1
Schatz, C.A.2
Kopitz, C.C.3
Adnane, L.4
McCabe, T.J.5
Trail, P.A.6
Ha, S.7
Chang, Y.S.8
Voznesensky, A.9
Ranges, G.10
Tamburini, P.11
-
100
-
-
77955424195
-
Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II
-
Maresca A, Supuran CT. Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II. Bioorg Med Chem Lett. 2010; 20: 4511-4514.
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 4511-4514
-
-
Maresca, A.1
Supuran, C.T.2
-
101
-
-
78449303755
-
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range
-
Maresca A, Scozzafava A, Supuran CT. 7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. Bioorg Med Chem Lett. 2010; 20: 7255-7258.
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 7255-7258
-
-
Maresca, A.1
Scozzafava, A.2
Supuran, C.T.3
-
102
-
-
79952808077
-
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis
-
Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT. Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis. J Med Chem. 2011; 54: 1896-1902.
-
(2011)
J Med Chem
, vol.54
, pp. 1896-1902
-
-
Pacchiano, F.1
Carta, F.2
McDonald, P.C.3
Lou, Y.4
Vullo, D.5
Scozzafava, A.6
Dedhar, S.7
Supuran, C.T.8
-
103
-
-
84055176334
-
Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors
-
DOI 10.1021/jm200983e
-
Touisni N, Maresca A, McDonald PC, Lou Y, Scozzafava A, Dedhar S, Winum JY, Supuran CT. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors. J Med Chem. 2011; 54: 8271-8277. DOI 10.1021/jm200983e
-
(2011)
J Med Chem
, vol.54
, pp. 8271-8277
-
-
Touisni, N.1
Maresca, A.2
McDonald, P.C.3
Lou, Y.4
Scozzafava, A.5
Dedhar, S.6
Winum, J.Y.7
Supuran, C.T.8
-
104
-
-
68049113519
-
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines
-
Morsy SM, Badawi AM, Cecchi A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines. J Enzyme Inhib Med Chem. 2009; 24: 499-505.
-
(2009)
J Enzyme Inhib Med Chem
, vol.24
, pp. 499-505
-
-
Morsy, S.M.1
Badawi, A.M.2
Cecchi, A.3
Scozzafava, A.4
Supuran, C.T.5
-
105
-
-
0033746355
-
Carbonic anhydrase inhibitors: aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors
-
Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors: aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors. J Enzyme Inhib. 2000; 15: 597-610.
-
(2000)
J Enzyme Inhib
, vol.15
, pp. 597-610
-
-
Supuran, C.T.1
Scozzafava, A.2
-
106
-
-
34250322126
-
Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors
-
Dubois L, Douma K, Supuran CT, Chiu RK, van Zandvoort MA, Pastorekova S, Scozzafava A, Wouters BG, Lambin P. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Radiother Oncol. 2007; 83: 367-373.
-
(2007)
Radiother Oncol
, vol.83
, pp. 367-373
-
-
Dubois, L.1
Douma, K.2
Supuran, C.T.3
Chiu, R.K.4
van Zandvoort, M.A.5
Pastorekova, S.6
Scozzafava, A.7
Wouters, B.G.8
Lambin, P.9
-
107
-
-
8844249356
-
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
-
Svastova E, Hulikova A, Rafajova M, Zat'ovicova M, Gibadulinova A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekova S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett. 2004; 577: 439-445.
-
(2004)
FEBS Lett
, vol.577
, pp. 439-445
-
-
Svastova, E.1
Hulikova, A.2
Rafajova, M.3
Zat'ovicova, M.4
Gibadulinova, A.5
Casini, A.6
Cecchi, A.7
Scozzafava, A.8
Supuran, C.T.9
Pastorek, J.10
Pastorekova, S.11
-
108
-
-
77952571665
-
Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007-2009
-
Poulsen SA. Carbonic anhydrase inhibition as a cancer therapy: a review of patent literature, 2007 - 2009. Expert Opin Ther Pat. 2010; 20: 795-806.
-
(2010)
Expert Opin Ther Pat
, vol.20
, pp. 795-806
-
-
Poulsen, S.A.1
-
109
-
-
67651091693
-
In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives
-
Ahlskog JK, Dumelin CE, Trussel S, Marlind J, Neri D. In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives. Bioorg Med Chem Lett. 2009; 19: 4851-4856.
-
(2009)
Bioorg Med Chem Lett
, vol.19
, pp. 4851-4856
-
-
Ahlskog, J.K.1
Dumelin, C.E.2
Trussel, S.3
Marlind, J.4
Neri, D.5
-
110
-
-
79954602278
-
Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds
-
Buller F, Steiner M, Frey K, Mircsof D, Scheuermann J, Kalisch M, Buhlmann P, Supuran CT, Neri D. Selection of Carbonic Anhydrase IX Inhibitors from One Million DNA-Encoded Compounds. ACS Chem Biol. 2011.
-
(2011)
ACS Chem Biol
-
-
Buller, F.1
Steiner, M.2
Frey, K.3
Mircsof, D.4
Scheuermann, J.5
Kalisch, M.6
Buhlmann, P.7
Supuran, C.T.8
Neri, D.9
-
111
-
-
69949128698
-
Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model
-
Dubois L, Lieuwes NG, Maresca A, Thiry A, Supuran CT, Scozzafava A, Wouters BG, Lambin P. Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model. Radiother Oncol. 2009; 92: 423-428.
-
(2009)
Radiother Oncol
, vol.92
, pp. 423-428
-
-
Dubois, L.1
Lieuwes, N.G.2
Maresca, A.3
Thiry, A.4
Supuran, C.T.5
Scozzafava, A.6
Wouters, B.G.7
Lambin, P.8
|